Literature DB >> 27040202

Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maraviroc.

Cameron Ball1, Shih-Feng Chou1, Yonghou Jiang1, Kim A Woodrow2.   

Abstract

Electrospun fibers show potential as a topical delivery system for vaginal microbicides. Previous reports have demonstrated delivery of anti-HIV and anti-STI (sexually transmitted infection) agents from fibers formulated using hydrophilic, hydrophobic, or pH-responsive polymers that result in rapid, prolonged, or stimuli-responsive release, respectively. However, coaxial electrospun fibers have yet to be evaluated as a highly tunable microbicide delivery vehicle. In this research, we explored the opportunities and limitations of a model coaxial electrospun fiber system to provide broad and tunable release rates for the HIV entry inhibitor maraviroc. Specifically, we prepared ethyl cellulose (EC)-shell and polyvinylpyrrolidone (PVP)-core fibers that were capable of releasing actives over a range of hours to several days. We further demonstrated simple and effective methods for combining core-shell fibers with rapid-release formulations to provide combined instantaneous and sustained maraviroc release. In addition, we investigated the effect of varying release media on maraviroc release from core-shell fibers, and found that release was strongly influenced by media surface tension and drug ionization. Finally, in vitro cell culture studies show that our fiber formulations were not cytotoxic and that electrospun maraviroc maintained similar antiviral activity compared to neat maraviroc.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coaxial; Core-shell; Drug delivery; Electrospinning; Maraviroc; Microbicide

Mesh:

Substances:

Year:  2016        PMID: 27040202      PMCID: PMC5283717          DOI: 10.1016/j.msec.2016.02.018

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  33 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

Review 2.  Microbicides and other topical strategies to prevent vaginal transmission of HIV.

Authors:  Michael M Lederman; Robin E Offord; Oliver Hartley
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

3.  Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery.

Authors:  Chaobo Huang; Stefaan J Soenen; Ellen van Gulck; Guido Vanham; Joanna Rejman; Serge Van Calenbergh; Chris Vervaet; Tom Coenye; Hans Verstraelen; Marleen Temmerman; Jo Demeester; Stefaan C De Smedt
Journal:  Biomaterials       Date:  2011-10-21       Impact factor: 12.479

4.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

5.  Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering.

Authors:  Yan Su; Qianqian Su; Wei Liu; Marcus Lim; Jayarama Reddy Venugopal; Xiumei Mo; Seeram Ramakrishna; Salem S Al-Deyab; Mohamed El-Newehy
Journal:  Acta Biomater       Date:  2011-11-09       Impact factor: 8.947

6.  Layered superhydrophobic meshes for controlled drug release.

Authors:  Eric J Falde; Jonathan D Freedman; Victoria L M Herrera; Stefan T Yohe; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2015-07-06       Impact factor: 9.776

7.  Ultrafast and fast bioerodible electrospun fiber mats for topical delivery of a hydrophilic peptide.

Authors:  Lauren K Macri; Larisa Sheihet; Adam J Singer; Joachim Kohn; Richard A F Clark
Journal:  J Control Release       Date:  2012-05-11       Impact factor: 9.776

8.  Slit-surface electrospinning: a novel process developed for high-throughput fabrication of core-sheath fibers.

Authors:  Xuri Yan; John Marini; Robert Mulligan; Abby Deleault; Upma Sharma; Michael P Brenner; Gregory C Rutledge; Toby Freyman; Quynh P Pham
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

9.  Drug-eluting fibers for HIV-1 inhibition and contraception.

Authors:  Cameron Ball; Emily Krogstad; Thanyanan Chaowanachan; Kim A Woodrow
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.

Authors:  Thanyanan Chaowanachan; Emily Krogstad; Cameron Ball; Kim A Woodrow
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more
  16 in total

1.  Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.

Authors:  Emily A Krogstad; Renuka Ramanathan; Christina Nhan; John C Kraft; Anna K Blakney; Shijie Cao; Rodney J Y Ho; Kim A Woodrow
Journal:  Biomaterials       Date:  2017-08-01       Impact factor: 12.479

2.  Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Authors:  Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Mohamed Mahmoud; Alfred B Jenson; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  J Control Release       Date:  2020-02-05       Impact factor: 9.776

Review 3.  Application of electrospun fibers for female reproductive health.

Authors:  Anna K Blakney; Yonghou Jiang; Kim A Woodrow
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.

Authors:  Tiffany N Grooms; Hung R Vuong; Kevin M Tyo; Danial A Malik; Lee B Sims; Carli P Whittington; Kenneth E Palmer; Nobuyuki Matoba; Jill M Steinbach-Rankins
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 5.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

6.  Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.

Authors:  Stella E Aniagyei; Lee B Sims; Danial A Malik; Kevin M Tyo; Keegan C Curry; Woihwan Kim; Daniel A Hodge; Jinghua Duan; Jill M Steinbach-Rankins
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-11-10       Impact factor: 7.328

7.  Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections.

Authors:  Kenneth E Palmer; Jill M Steinbach-Rankins; Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Alfred B Jenson; Joshua L Fuqua
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

Review 8.  Perspectives on Existing and Novel Alternative Intravaginal Probiotic Delivery Methods in the Context of Bacterial Vaginosis Infection.

Authors:  Priyadarshini Chandrashekhar; Farnaz Minooei; Wenndy Arreguin; Mohammadali Masigol; Jill M Steinbach-Rankins
Journal:  AAPS J       Date:  2021-05-10       Impact factor: 4.009

Review 9.  Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.

Authors:  Matthew R Beymer; Ian W Holloway; Craig Pulsipher; Raphael J Landovitz
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.495

10.  In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.

Authors:  Farnaz Minooei; Joel R Fried; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  Int J Nanomedicine       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.